Open AccessP1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT‐OF‐CARE ANTI CD19 CAR T‐CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
Author(s) -
Fried S.,
Besser M. J.,
Shkury E.,
Yerushalmi R.,
ShemTov N.,
Danylesko I.,
Jacoby E.,
Itzhaki O.,
Shouval R.,
Kedmi M.,
Shimoni A.,
Nagler A.,
Avigdor A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847300.61295.fe
Subject(s) - medicine , leukapheresis , fludarabine , follicular lymphoma , cyclophosphamide , refractory (planetary science) , gastroenterology , surgery , lymphoma , immunology , oncology , chemotherapy , cd34 , genetics , physics , stem cell , astrobiology , biology